• $1.7M
    Market Cap
  • -58.06%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
02/28/2025
02/29/2024
02/28/2023
02/28/2022
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.0M
+20.92%
-864,999
+20.39%
-718,505
-5.40%
-759,510
-25.75%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
1.4M
+3.80%
1.3M
+45.74%
916,292
-6.18%
976,656
-24.97%
Operating Profit
-1.4M
+3.80%
-1.3M
+45.74%
-916,292
-6.18%
-976,656
-24.97%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
97,773
0.00%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
-100.00%
97,773
0.00%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
97,773
0.00%
Income before Taxes
-1.4M
+3.80%
-1.3M
+45.74%
-916,292
-6.18%
-976,656
-18.88%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.4M
+3.80%
-1.3M
+45.74%
-916,292
-6.18%
-976,656
-18.88%
Net Income from Continuing Operations Applicable to Common
-1.4M
+3.80%
-1.3M
+45.74%
-916,292
-6.18%
-976,656
-18.88%
Basic EPS and Net Income
-0.01
0.00%
-0.01
0.00%
-0.01
0.00%
-0.01
0.00%
Diluted EPS and Net Income
-0.01
0.00%
-0.01
0.00%
-0.01
0.00%
-0.01
0.00%
Basic Weighted Average Shares
131.4M
0.00%
131.4M
0.00%
131.4M
0.00%
131.4M
0.00%
Diluted Weighted Average Shares
131.4M
0.00%
131.4M
0.00%
131.4M
0.00%
131.4M
0.00%
Balance Sheet
Cash and Cash Equivalents
847
-35.34%
1,310
+40.26%
934
-72.38%
3,382
+5,354.84%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
847
-35.34%
1,310
+40.26%
934
-72.38%
3,382
+5,354.84%
Total Current Assets
847
-63.33%
2,310
+19.44%
1,934
-58.51%
4,661
+387.55%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
847
-63.33%
2,310
+19.44%
1,934
-58.51%
4,661
+387.55%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
42,484
+54.86%
27,433
+75.17%
15,661
-56.46%
35,967
-23.15%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
160,000
0.00%
Total Liabilities
42,484
+54.86%
27,433
+75.17%
15,661
+353.29%
3,455
-92.62%
Retained Earnings
-129.5M
+1.08%
-128.1M
+1.05%
-126.8M
+0.73%
-125.8M
+0.78%
Total Stockholders Equity
-41,637
+65.73%
-25,123
+83.02%
-13,727
-1,238.23%
1,206
+102.63%
Total Shares Outstanding
131.4M
0.00%
131.4M
0.00%
131.4M
0.00%
131.4M
0.00%
Cash Flow
Cash from Operating Activities
-388,531
-25.82%
-523,780
+109.92%
-249,516
-23.25%
-325,098
-17.57%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
388,068
-25.96%
524,156
+112.15%
247,068
-24.77%
328,418
-16.70%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-87,817.99%
+39.54%
-62,932.66%
+126.48%
-27,787.48%
-20.09%
-34,775.00%
+200.51%
Return on Equity
4,152.81%
-39.59%
6,874.81%
-53.03%
14,636.08%
+234.46%
4,375.99%
+260.60%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.02
-76.37%
0.08
-31.82%
0.12
-4.71%
0.13
+535.29%
Cash Ratio
0.02
-58.37%
0.05
-19.80%
0.06
-36.60%
0.09
+7,130.77%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow